KLG Stock +78.58% In 3 Months Since We Picked KLG Stock +78.58% In 3 Months Since We Picked Unlock All Top Buy Picks
NASDAQ:ARGS
Delisted

Argos Therapeutics Fund Price (Quote)

$0.0536
+0 (+0%)
At Close: Apr 15, 2020

Range Low Price High Price Comment
30 days $0.0536 $0.0536 Wednesday, 15th Apr 2020 ARGS stock ended at $0.0536. During the day the stock fluctuated 0% from a day low at $0.0536 to a day high of $0.0536.
90 days $0.0536 $0.0536
52 weeks $0.0350 $0.0840

Historical Argos Therapeutics prices

Date Open High Low Close Volume
Mar 10, 2020 $0.0536 $0.0536 $0.0536 $0.0536 0
Mar 09, 2020 $0.0536 $0.0536 $0.0536 $0.0536 0
Mar 06, 2020 $0.0536 $0.0536 $0.0536 $0.0536 0
Mar 05, 2020 $0.0536 $0.0536 $0.0536 $0.0536 0
Mar 04, 2020 $0.0536 $0.0536 $0.0536 $0.0536 0
Mar 03, 2020 $0.0536 $0.0536 $0.0536 $0.0536 0
Mar 02, 2020 $0.0536 $0.0536 $0.0536 $0.0536 0
Feb 28, 2020 $0.0536 $0.0536 $0.0536 $0.0536 0
Feb 27, 2020 $0.0536 $0.0536 $0.0536 $0.0536 0
Feb 26, 2020 $0.0536 $0.0536 $0.0536 $0.0536 0
Feb 25, 2020 $0.0536 $0.0536 $0.0536 $0.0536 0
Feb 24, 2020 $0.0536 $0.0536 $0.0536 $0.0536 0
Feb 21, 2020 $0.0536 $0.0536 $0.0536 $0.0536 0
Feb 20, 2020 $0.0536 $0.0536 $0.0536 $0.0536 0
Feb 19, 2020 $0.0536 $0.0536 $0.0536 $0.0536 0
Feb 18, 2020 $0.0536 $0.0536 $0.0536 $0.0536 0
Feb 14, 2020 $0.0536 $0.0536 $0.0536 $0.0536 0
Feb 13, 2020 $0.0536 $0.0536 $0.0536 $0.0536 0
Feb 12, 2020 $0.0536 $0.0536 $0.0536 $0.0536 0
Feb 11, 2020 $0.0536 $0.0536 $0.0536 $0.0536 0
Feb 10, 2020 $0.0536 $0.0536 $0.0536 $0.0536 0
Feb 07, 2020 $0.0536 $0.0536 $0.0536 $0.0536 0
Feb 06, 2020 $0.0536 $0.0536 $0.0536 $0.0536 0
Feb 05, 2020 $0.0536 $0.0536 $0.0536 $0.0536 0
Feb 04, 2020 $0.0536 $0.0536 $0.0536 $0.0536 0
Click to get the best stock tips daily for free!

About Argos Therapeutics

Argos Therapeutics, Inc. focuses on the development and commercialization of individualized immunotherapies for the treatment of cancer and infectious diseases in North America. The company develops immunotherapies based on Arcelis, its proprietary technology platform. Its development stage products include AGS-003, which is under Phase III clinical trials for the treatment of metastatic renal cell carcinoma and other cancers; and AGS-004, which ... ARGS Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT